Search Results - "Byar, D P"

Projecting individualized probabilities of developing breast cancer for white females who are being examined annually by Gail, M H, Brinton, L A, Byar, D P, Corle, D K, Green, S B, Schairer, C, Mulvihill, J J

“…To assist in medical counseling, we present a method to estimate the chance that a woman with given age and risk factors will develop breast cancer over a…”
Get more information

The ecological fallacy by Piantadosi, S, Byar, D P, Green, S B

Get more information

Design Considerations for AIDS Trials by Byar, David P, Collins, Rory, Peto, Julian, Schoenfeld, David A, Freedman, Laurence S, Ellenberg, Susan S, Green, Sylvan B, Anderson, James R, Amato, David A, Peto, Richard, Gail, Mitchell, Davis, Roger, Peto, Tim, Simon, Richard, De Gruttola, Victor, Finkelstein, Dianne M, Gatsonis, Constantine, Gelber, Richard D, Lagakos, Stephen, Lefkopoulou, Myrto, Tsiatis, Anastasios A, Zelen, Marvin

“…Statisticians and clinicians involved in the design and conduct of trials of new treatments for the acquired immunodeficiency syndrome (AIDS) have realized…”
Get full text

Estimating the population attributable risk for multiple risk factors using case-control data by Bruzzi, P, Green, S B, Byar, D P, Brinton, L A, Schairer, C

“…A straightforward and unified approach is presented for the calculation of the population attributable risk per cent (etiologic fraction) in the general…”
Get more information

Assessing the gain in efficiency due to matching in a community intervention study by Freedman, L S, Green, S B, Byar, D P

“…COMMIT (Community Intervention Trial for Smoking Cessation) is a randomized study employing a matched pairs design. Pairs of communities were selected on the…”
Get more information

Why Data Bases Should Not Replace Randomized Clinical Trials by Byar, David P.

“…Advances in computer technology have made it possible to store large amounts of observational data concerning treatment of patients for medical disorders. It…”
Get full text

Clinical staging for cutaneous T-cell lymphoma by Lamberg, S I, Green, S B, Byar, D P, Block, J B, Clendenning, W E, Douglas, M C, Epstein, Jr, E H, Fuks, Z Y, Golitz, L E, Lorincz, A L

“…The Mycosis Fungoides Cooperative Group has been following patients with cutaneous T-cell lymphoma, including mycosis fungoides and the Sézary syndrome…”
Get more information

The study of markers of biological effect in cancer prevention research trials by Greenwald, P, Witkin, K M, Malone, W F, Byar, D P, Freedman, L S, Stern, H R

“…Biological markers may provide a valuable tool for the development of cancer prevention agents, for monitoring patient compliance to a selected intervention,…”
Get more information

Screening geographic areas for unusual survival experience or stage at diagnosis with application to breast and colon cancer by Piantadosi, S, Byar, D P, Gail, M H

“…An approach was devised for the problem of detecting geographic areas with poor survival for cancer patients. Methods were proposed to deal with the two major…”
Get more information

Problems with using observational databases to compare treatments by Byar, D P

Get more information

Testing Hypotheses in Case-Control Studies-Equivalence of Mantel-Haenszel Statistics and Logit Score Tests by Day, N. E., Byar, D. P.

“…The two approaches in common use for the analysis of case-control studies are cross-classification by confounding variables, and modeling the logarithm of the…”
Get full text

A Comparison of Reflected Versus Test-Based Confidence Intervals for the Median Survival Time, Based on Censored Data by Slud, Eric V., Byar, David P., Green, Sylvan B.

“…The small-sample performance of some recently proposed nonparametric methods of constructing confidence intervals for the median survival time, based on…”
Get full text

Superiority of PCNU over AZQ in the treatment of primary brain tumors: results of a prospective randomized trial (81-20) by the brain tumor study group by MALKIN, M. G, GREEN, S. B, MEALEY, J. JR, ROBERTSON, J. T, SELKER, R. G, VAN GILDER, J. C, BYAR, D. P, STRIKE, T. A, BURGER, P. C, VOGEL, F. S, PISTENMAA, D. A, MAHALEY, M. S, RANSOHOFF, J, SHAPIRO, W. R

“…A two-arm randomized clinical trial was performed to determine the efficacy of PCNU and AZQ in the treatment of de novo or recurrent primary brain tumors. An…”
Get full text

Quantification of the effects of preventive measures by Kaldor, J, Byar, D P

Get more information

Dependent Competing Risks and the Latent-Failure Model by Slud, Eric V., Byar, David P., Schatzkin, Arthur, Prentice, Ross, Kalbfleisch, Jack

Get full text

The Dietary Fat—Breast Cancer Hypothesis Is Alive by Schatzkin, Arthur, Greenwald, Peter, Byar, David P, Clifford, Carolyn K

“…Data from animal experiments and human correlation studies strongly support the dietary fat—breast cancer hypothesis. Moreover, a causal relation between…”
Get full text

Incidence of cardiovascular disease and death in patients receiving diethylstilbestrol for carcinoma of the prostate by Blackard, C E, Doe, R P, Mellinger, G T, Byar, D P

Get more information

The design of cancer prevention trials by Byar, D P

Get more information

Some interrelationships among the regression coefficient estimates arising in a class of models appropriate to response-time data by Byar, D P, Mantel, N

“…Interrelationships among three response-time models which incorporate covariate information are explored. The most general of these models is the…”
Get full text

Factorial designs for randomized clinical trials by Byar, D P, Piantadosi, S

Get more information